Tags:DevelopmentDrugEngineeringFastFutureHealthTechHumanMedTechPlatformWebsite
Human livesdrive our discovery of microbiome therapeutics Finch is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs. Human-First Discovery platform Our platform is built to rapidly translate insights mined from compelling human data into the development of novel microbiome therapeutics. Learn more Pipeline […]
Location: United States, Massachusetts, Somerville
Member count: 51-200
Total raised: $179M
Founded date: 2017

Investors 5

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
21.09.2020Series D$90M-ocvpartner...
22.08.2019Series C$53M-ocvpartner...
01.03.2018Series B$36M-citybizlis...

Mentions in press and media 28

DateTitleDescriptionCategoryAuthorSource
19.04.2022Bear mar­k...Much ink has been spilled over...-Max Gelmanendpts.com...
20.10.2021Finch Ther...Harnessing the Genomic Revolut...--marketscre...
03.06.2021Gut therap...MicrobiomX’s device for stool ...-Charlotte ...geekwire.c...
21.09.2020Microbiome...Clinical-stage microbiome drug...--pulse2.com...
17.09.2020Finch Ther... SOMERVILLE, MA, Finch Therap...--vcnewsdail...
17.09.2020OCV Partne...Somerville, MA, September 17, ...--ocvpartner...
17.09.2020Finch Ther...SOMERVILLE, Mass.--(BUSINESS W...--citybizlis...
17.09.2020Finch nets...According to the Centers for D...Biotech-fiercebiot...
17.09.2020Finch Ther...Finch Therapeutics Group, Inc....USA-finsmes.co...
08.01.2020Finch Ther...Somerville, MA (January 8, 202...--ocvpartner...
Show more